TABLE III.
PROPORTION OF INFECTIONS THAT WERE LIFE-THREATENING OR FATAL DURING INDUCTION BY SITE
| All organisms |
Bacteria | Gram Positive |
Gram Negative |
All Fungi |
Yeasts | Molds | Viruses | |
|---|---|---|---|---|---|---|---|---|
| Blood | 137/227 (60.4%) |
131/218 (60.1%) |
97/170 (57.1%) |
51/80 (63.8%) |
13/18 (72.2%) |
11/15 (73.3%) |
2/3 (66.7%) |
3 /4 (75.0%) |
| Pulmonary | 25/31 (80.7%) |
6/9 (66.7%) |
4/4 (100%) |
0/1 (0%) |
23/24 (95.8%) |
5/6 (83.3%) |
20/20 (100.0%) |
1/3 (33.3%) |
| Upper GI | 17/53 (32.1%) |
6/16 (37.5%) |
5/14 (35.7%) |
2/5 (40%) |
5/21 (23.8%) |
4/20 (20.0%) |
2/2 (100.0%) |
8/20 (40.0%) |
| Lower GI | 23/58 (39.7%) |
16/35 (45.7%) |
13/29 (44.8%) |
3/7 (42.9%) |
6/15 (40.0%) |
5/14 (35.7%) |
1/1 (100.0%) |
1/6 (16.7%) |
| Skin and Subcutaneous | 10/48 (20.8%) |
7/31 (22.6%) |
5/25 (20%) |
2/7 (28.6%) |
2/8 (25.0%) |
0/4 (0%) |
2/4 (50.0% |
1/10 (10.0%) |
| CNS | 1/1 (100.0%) |
0 | 0 | 0 | 1/1 (100.0%) |
0 | 1/1 (100.0%) |
0 |
| Urinary Tract | 8/47 (17.0%) |
1/29 (3.5%) |
1/17 (5.9%) |
0/14 (0%) |
6/20 (30.0%) |
6/20 (30.0%) |
0 | 1/2 (50.0%) |
| CVC | 25/58 (43.1%) |
20/54 (37.0%) |
7/14 (50.0%) |
6/24 (25.0%) |
5/7 (71.4%) |
4/6 (66.7%) |
2/2 (100.0%) |
0 |
| Liver | 5/8 (62.5%) |
3/4 (75.0%) |
3/4 (75.0%) |
0 | 2/4 (50.0%) |
1/3 (33.3%) |
1/1 (100.0%) |
0 |
| Upper Respiratory | 10/23 (43.5%) |
2/6 (33.3%) |
2/5 (40.0%) |
0/2 (0%) |
4/7 (57.1%) |
2/3 (66.7%) |
2/4 (50.0%) |
4/10 (40.0%) |
Abbreviations: CNS – central nervous system; CVC – central venous catheter